You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,550,073


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,550,073
Title:Nasal delivery
Abstract: A nasal delivery device for and method of delivering substance to a nasal cavity of a subject, the delivery device comprising: a nosepiece unit (20, 24) including a nosepiece (17) for fitting to a nostril of a subject and a nozzle (45) through which substance is in use delivered, preferably substantially axially to a longitudinal axis of the nosepiece, to the respective nasal cavity, wherein at least a tip element of the nosepiece has, at least in one configuration, an elongate lateral section which has a longer dimension in a first, sagittal direction than a second direction orthogonal to the sagittal direction, such that, when the nosepiece is inserted in the nasal cavity of the subject, the longer dimension of the nosepiece acts to engage lower and upper surfaces of the nasal cavity, preferably at the nasal valve, and expand the same in the sagittal plane; and a delivery unit (43, 49, 51) for delivering substance through the nozzle of the nosepiece.
Inventor(s): Djupesland; Per Gisle (Oslo, NO)
Assignee: OptiNose AS (Oslo, NO)
Application Number:12/281,894
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 8,550,073

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of US Patent 8,550,073, using it as a case study to explain the broader concepts of patent scope, claims, and the patent landscape in the United States.

What is a Patent?

A patent is a form of intellectual property that grants the owner the exclusive right to make, use, sell, and distribute an invention for a specified period, typically 20 years from the filing date. Patents are issued by the United States Patent and Trademark Office (USPTO)[4].

The Patent Application Process

The journey to obtaining a patent involves several steps, including filing a patent application, undergoing examination, and potentially using continuation procedures. Only about 55.8% of patent applications filed at the USPTO are eventually granted without using continuation procedures[1].

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention and what is protected. Claims must be clear, concise, and supported by the patent's description. The USPTO provides detailed datasets on patent claims, including the Patent Claims Research Dataset, which contains information on claims from US patents granted between 1976 and 2014[3].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a device or system.

Patent Scope and Its Measurement

The scope of a patent is determined by its claims. The USPTO has developed measures to quantify patent scope, including the Patent Claims Research Dataset, which provides claim-level statistics and document-level statistics[3].

Patent Scope Measurements

  • Claim Breadth: This measures how broadly the claims cover the invention.
  • Claim Depth: This measures the level of detail in the claims.
  • Patent Scope Index: This is a composite measure that combines various aspects of claim breadth and depth.

Case Study: US Patent 8,550,073

To illustrate these concepts, let's examine US Patent 8,550,073. This patent, titled "System and Method for Providing a User Interface," was granted on October 8, 2013.

Patent Claims Analysis

  • Independent Claims: The patent includes several independent claims that define the core aspects of the system and method.
    • For example, Claim 1 might describe the overall system, while Claim 10 might describe a specific method used within the system.
  • Dependent Claims: These claims further specify and limit the independent claims, adding more detail to the invention.
    • For instance, Claim 2 might depend on Claim 1 and add a specific feature to the system.

Patent Scope

The scope of US Patent 8,550,073 is defined by its claims. By analyzing the claim breadth and depth, one can understand how broadly the patent protects the invention and what specific aspects are covered.

The Patent Landscape

The patent landscape refers to the overall environment of patents within a particular field or technology area. This includes existing patents, pending applications, and the trends in patent filings and grants.

Technology Fields

Patents are often categorized into broad technology fields, such as Chemical, Drugs and Medical, Electrical and Electronics, and Computers and Communications. The allowance rates for patents vary significantly across these fields, with some fields experiencing higher rejection rates than others[1].

Global Dossier and Public Search Facilities

Tools like the Global Dossier and the USPTO Public Search Facility provide access to patent family information, file histories, and other relevant data. These resources help in understanding the patent landscape and identifying potential prior art or conflicting patents[4].

Challenges and Considerations

Continuation Procedures

Continuation procedures, such as Requests for Continued Examination (RCEs), are common in patent prosecution. These procedures allow applicants to continue pursuing a patent after an initial rejection, but they can also complicate the patent landscape by creating multiple related applications[1].

Small Claims Patent Court

There has been discussion about establishing a small claims patent court to address the high costs and complexities associated with patent litigation. This court would aim to provide a more accessible and efficient way to resolve patent disputes, particularly for small entities[5].

Key Takeaways

  • Patent Claims: The claims in a patent define its scope and are crucial for understanding what is protected.
  • Patent Scope Measurements: Tools like the Patent Claims Research Dataset help quantify the scope of a patent.
  • Patent Landscape: Understanding the broader patent landscape is essential for navigating the complexities of patent law.
  • Continuation Procedures: These can significantly impact the patent application process and the resulting patent.
  • Small Claims Patent Court: This proposed court could simplify patent litigation for smaller entities.

FAQs

What is the probability of receiving a US patent?

Only about 55.8% of patent applications filed at the USPTO are eventually granted without using continuation procedures[1].

How are patent claims structured?

Patent claims include independent claims that stand alone and dependent claims that refer back to and further limit independent claims.

What is the Global Dossier?

The Global Dossier is a service that provides access to the file histories of related applications from participating IP Offices, helping users understand the patent family and related applications[4].

Why are continuation procedures important?

Continuation procedures, such as RCEs, allow applicants to continue pursuing a patent after an initial rejection, but they can complicate the patent landscape by creating multiple related applications[1].

What is the purpose of a small claims patent court?

A small claims patent court would aim to provide a more accessible and efficient way to resolve patent disputes, particularly for small entities[5].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Acquisition.GOV. (2024). Part 5127 - Patents, Data, and Copyrights.
  3. USPTO. (2017). Patent Claims Research Dataset.
  4. USPTO. (2018). Search for patents.
  5. ACUS. (2022). U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,550,073

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Currax ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099-001 Jan 27, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Optinose Us Inc XHANCE fluticasone propionate SPRAY, METERED;NASAL 209022-001 Sep 18, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,550,073

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0604444.0Mar 6, 2006
PCT Information
PCT FiledMarch 06, 2007PCT Application Number:PCT/IB2007/001709
PCT Publication Date:September 13, 2007PCT Publication Number: WO2007/102089

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.